More Articles Back to Article
Treatment target identified for leukemia stem cells
Australian scientists are studying the potential for using an antibody to block interaction of the RSPO3 and LGR4 molecules and prevent self-renewal of leukemia stem cells, according to a study in the journal Cancer Cell. "Leukemia stem cells have their own protective mechanisms that make them resistant to anticancer drugs," said researcher Jenny Wang of the Children's Cancer Institute in Australia. Genetic Engineering & Biotechnology News (6/22)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!